Cargando…

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids

OBJECTIVES: To examine whether the inter-individual variation in constipation among patients receiving opioids for cancer pain is associated with genetic or non-genetic factors. METHODS: Cancer patients receiving opioids were included from 17 centers in 11 European countries. Intensity of constipati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laugsand, Eivor A, Skorpen, Frank, Kaasa, Stein, Sabatowski, Rainer, Strasser, Florian, Fayers, Peter, Klepstad, Pål
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816247/ https://www.ncbi.nlm.nih.gov/pubmed/26087058 http://dx.doi.org/10.1038/ctg.2015.19

Ejemplares similares

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study
por: Laugsand, Eivor A, et al.
Publicado: (2010)

Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
por: Kurita, Geana Paula, et al.
Publicado: (2016)

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

Inadequate symptom control in advanced cancer patients across Europe
por: Laugsand, Eivor A., et al.
Publicado: (2010)

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
por: Andersen, Sonja, et al.
Publicado: (2013)

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
por: Colombo, Francesca, et al.
Publicado: (2020)

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015)

DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
por: Olesen, Anne Estrup, et al.
Publicado: (2018)

The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
por: Paulsen, Ørnulf, et al.
Publicado: (2017)

Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
por: Barratt, Daniel T., et al.
Publicado: (2015)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2018)

The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2020)

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory
por: Stenseth, Guri, et al.
Publicado: (2007)

Chronic Constipation
por: Kinney, Jno. W.
Publicado: (1896)

Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
por: Bye, Asta, et al.
Publicado: (2022)

Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study
por: Brenne, Siv S., et al.
Publicado: (2023)

Strychnia in Habitual Constipation
por: Neyman, E. H.
Publicado: (1862)

Management of a life-threatening intercostal artery bleeding, difficult to visualize in open surgery: a case report
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Hysterectomy Does Not Cause Constipation
por: Roovers, Jan-Paul, et al.
Publicado: (2008)

The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
por: Vagnildhaug, Ola Magne, et al.
Publicado: (2017)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

Psychosocial risks for constipation and soiling in primary school children
por: Joinson, Carol, et al.
Publicado: (2018)

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
por: Klepstad, Pål, et al.
Publicado: (2004)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
por: Løhre, Erik Torbjørn, et al.
Publicado: (2018)

Genetic Associations With White Matter Hyperintensities Confer Risk of Lacunar Stroke
por: Traylor, Matthew, et al.
Publicado: (2016)

Differences in Common Genetic Predisposition to Ischemic Stroke by Age and Sex
por: Traylor, Matthew, et al.
Publicado: (2015)

Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation
por: Chokhavatia, Sita, et al.
Publicado: (2016)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
por: Andreassen, Trine Naalsund, et al.
Publicado: (2011)

A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy
por: Webster, Lynn R, et al.
Publicado: (2020)

Methylnaltrexone in the treatment of opioid-induced constipation
por: Meerveld, Beverley Greenwood-Van, et al.
Publicado: (2008)

Validation of Doloplus-2 among nonverbal nursing home patients - an evaluation of Doloplus-2 in a clinical setting
por: Torvik, Karin, et al.
Publicado: (2010)

Genetic Architecture of Lacunar Stroke
por: Traylor, Matthew, et al.
Publicado: (2015)

Doloplus-2, a valid tool for behavioural pain assessment?
por: Hølen, Jacob C, et al.
Publicado: (2007)

Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication
por: Majewski, Marek, et al.
Publicado: (2014)

Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age
por: Wild, James, et al.
Publicado: (2020)

Abdominal Pain due to Opioid-Induced Constipation
por: Jacobs, Chelsea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uopthh9omk09hee0c72ut30a8p